ISPC

8-K - iSpecimen Inc. (0001558569) (Filer)

8-K - iSpecimen Inc. (0001558569) (Filer)

Woburn, Massachusetts--(Newsfile Corp. - April 9, 2026) - iSpecimen (NASDAQ:ISPC), an online marketplace for human biospecimens, has implemented a streamlined shipping model that enables direct shipment of biospecimens from supplier sites to customers, both domestically and internationally.By reducing reliance on centralized hub processing, the new model simplifies logistics and eliminates multi-step routing. Previously, shipments often required routing through a central hub, which could add 7-14 days to transit times. Under the updated approach, domestic shipments can now be delivered in as little as 1-2 days, reducing transit times by approximately 70-85% while also lowering overall shippi

10-K - iSpecimen Inc. (0001558569) (Filer)

NT 10-K - iSpecimen Inc. (0001558569) (Filer)

Woburn, Massachusetts--(Newsfile Corp. - March 16, 2026) - iSpecimen Inc. (NASDAQ:ISPC) (the "Company"), a leading provider of human biospecimens for research, is proud to announce recent milestones that demonstrate the responsiveness and capabilities of its site network. Over the past several months, iSpecimen has been actively supporting customer research by sourcing high-quality respiratory samples, with a particular focus on influenza. Most recently, iSpecimen successfully collected approximately 500 influenza swab samples over a period of several weeks to support a customer research project—demonstrating its ability to respond quickly to time-sensitive research needs. The rapid turnarou

8-K - iSpecimen Inc. (0001558569) (Filer)

Strengthens iSpecimen's next-generation marketplace platform Woburn, MA, March 12, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (the "Company") (NASDAQ:ISPC), a leading technology marketplace connecting researchers with biospecimen suppliers, today announced the launch of its new AI-powered Inventory Agent, a purpose-built tool designed to help accelerate the process of reviewing incoming biospecimen requests and matching them with available inventory across its global supplier network. The internally developed AI agent analyzes incoming request criteria and is designed to identify potential biospecimen matches, enabling the iSpecimen team to respond to research inquiries with greater speed

DEFA14A - iSpecimen Inc. (0001558569) (Filer)

8-K - iSpecimen Inc. (0001558569) (Filer)

8-K - iSpecimen Inc. (0001558569) (Filer)

8-K - iSpecimen Inc. (0001558569) (Filer)

Live Production Marketplace Now AvailableWoburn, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ:ISPC) today announced the successful completion of Milestone 2, System Integration and Marketplace Activation, marking a pivotal step in the SalesStack digital transformation journey. The milestone delivers a fully integrated, live marketplace that connects customer requests with supplier inventories, enabling streamlined operations, reduced costs, and a foundation for future growth.Chief Executive Officer Ms. Katie Field commented, "This Milestone 2 achievement demonstrates end-to-end system integration, legacy data migration, and activation of a production-ready Sale

Lexington, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ:ISPC), a leading provider of human biospecimens for research, is proud to announce recent milestones that demonstrate the strength, responsiveness, and reliability of its site network.Over the past several months, iSpecimen has been actively supporting customer research by sourcing high-quality respiratory samples, with a particular focus on influenza. Most recently, iSpecimen successfully collected 500 influenza swab samples in just a few weeks to support a customer research project—demonstrating its ability to respond quickly to time-sensitive research needs. The rapid turnaround and quality of the speci

424B3 - iSpecimen Inc. (0001558569) (Filer)

EFFECT - iSpecimen Inc. (0001558569) (Filer)

8-K - iSpecimen Inc. (0001558569) (Filer)

8-K/A - iSpecimen Inc. (0001558569) (Filer)

DEFA14A - iSpecimen Inc. (0001558569) (Filer)

MANHATTAN, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co., a Manhattan-headquartered investment bank and broker-dealer, today announced that it acted as the exclusive placement agent in connection with iSpecimen Inc.'s (NASDAQ:ISPC) private placement, raising approximately $5.5 million in gross proceeds before fees and expenses. The transaction reflects continued capital markets interest in differentiated healthcare technology platforms that support medical research and discovery. iSpecimen operates an online global marketplace connecting scientists with healthcare specimen providers, enabling more efficient access to biospecimens critical for clinical and translational researc

D - iSpecimen Inc. (0001558569) (Filer)

8-K - iSpecimen Inc. (0001558569) (Filer)

8-K - iSpecimen Inc. (0001558569) (Filer)

8-K - iSpecimen Inc. (0001558569) (Filer)

424B3 - iSpecimen Inc. (0001558569) (Filer)